Cardiovascular Outcomes of Semaglutide vs Dulaglutide in Nonobese Type II Diabetes Patients With HFpEF

Saved in:

Bibliographic Details
Main Authors:	Patrick A. Kwaah, MBChB, Samuel A. Mensah, MBChB, Abraham Carboo, MBChB, MPH, Hamza A. Rashid, MBBS, Emmanuel A. Agyemang, MBChB, Grace Appah, MBChB, Smith K. Frimpong, MD
Format:	Article
Language:	English
Published:	Elsevier 2025-07-01
Series:	JACC: Advances
Subjects:	cardiovascular outcomes dulaglutide GLP-1 receptor agonists heart failure with preserved ejection fraction (HFpEF) non-obese semaglutide
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772963X25002777
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet